1-4 of 4
Hiltrud Nisters-Backes
Close
Sort by
Journal Articles

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Clinical Trials & Observations
Teresa V. Halbsguth, Lucia Nogová, Horst Mueller, Michal Sieniawski, Dennis A. Eichenauer, Thomas Schober, Hiltrud Nisters-Backes, Peter Borchmann, Volker Diehl, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2010) 116 (12): 2026–2032.
https://doi.org/10.1182/blood-2009-11-253211
Published: 2010
Journal Articles

“Quality of Life (QoL) in the Randomised HD10-12 Trials of the German Hodgkin Study Group (GHSG): Sexual Functions (SX) in Hodgkin Lymphoma (HL) Patients Decrease by Disease Stage and Improve After Therapy Depending On Stage and Treatment Modality.”.

Karolin Behringer, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Teresa Halbsguth, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, MD, Peter Borchmann
Journal: Blood
Blood (2009) 114 (22): 896.
https://doi.org/10.1182/blood.V114.22.896.896
Published: 2009
Journal Articles

Quality of Life in a 2-Year Follow-up: Signs of PNP Predicting Cognitive Functioning in Survivors Treated in the HD10–12 Trials of the German Hodgkin Study Group (GHSG).

Teresa Halbsguth, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Karolin Behringer, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2008) 112 (11): 1455.
https://doi.org/10.1182/blood.V112.11.1455.1455
Published: 2008
Journal Articles

The Newly Developed Modified BEACOPP-Regimen (BACOPP) Is Active and Feasible in Elderly Patients with Hodgkin Lymphoma: Results of a Phase II Study of the German Hodgkin Study Group (GHSG)

Horst Mueller, Lucia Nogova, Dennis A Eichenauer, Teresa Halbsguth, Hiltrud Nisters-Backes, Thomas Schober, Hartmut Eimermacher, Peter Borchmann, Michael Fuchs, Andreas Engert, Andreas Josting
Journal: Blood
Blood (2008) 112 (11): 2600.
https://doi.org/10.1182/blood.V112.11.2600.2600
Published: 2008